期刊
IMMUNOLOGICAL REVIEWS
卷 242, 期 -, 页码 233-246出版社
WILEY-BLACKWELL
DOI: 10.1111/j.1600-065X.2011.01027.x
关键词
atopic dermatitis; antimicrobial peptides; eczema herpeticum; epidermal barrier; filaggrin; Staphylococcus aureus
类别
资金
- NIH/NIAID [N01 AI 40029, AR41256]
Atopic dermatitis (AD) is an important chronic or relapsing inflammatory skin disease that often precedes asthma and allergic disorders. New insights into the genetics and pathophysiology of AD point to an important role of structural abnormalities in the epidermis as well as immune dysregulation not only for this skin disease but also for the development of asthma and allergies. Patients with AD have a unique predisposition to colonization or infection by microbial organisms, most notably Staphylococcus aureus and herpes simplex virus. Measures directed at healing and protecting the skin barrier and addressing the immune dysregulation are essential in the treatment of patients with AD, and early intervention may improve outcomes for both the skin disease as well as other target organs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据